466 related articles for article (PubMed ID: 29229668)
1. Multiple Myeloma and Bone: The Fatal Interaction.
Marino S; Roodman GD
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29229668
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of the bone disease of multiple myeloma.
Edwards CM; Zhuang J; Mundy GR
Bone; 2008 Jun; 42(6):1007-13. PubMed ID: 18406675
[TBL] [Abstract][Full Text] [Related]
3. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of myeloma bone disease.
Esteve FR; Roodman GD
Best Pract Res Clin Haematol; 2007 Dec; 20(4):613-24. PubMed ID: 18070709
[TBL] [Abstract][Full Text] [Related]
5. New agents in the Treatment of Myeloma Bone Disease.
Ring ES; Lawson MA; Snowden JA; Jolley I; Chantry AD
Calcif Tissue Int; 2018 Feb; 102(2):196-209. PubMed ID: 29098361
[TBL] [Abstract][Full Text] [Related]
6. [Bone disease in multiple myeloma and its mechanism].
Abe M
Clin Calcium; 2006 Apr; 16(4):565- 71. PubMed ID: 16582506
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of myeloma bone disease.
Roodman GD
J Cell Biochem; 2010 Feb; 109(2):283-91. PubMed ID: 20014067
[TBL] [Abstract][Full Text] [Related]
8. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
Bataille R; Chappard D; Klein B
Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
[TBL] [Abstract][Full Text] [Related]
9. Tumor-host cell interactions in the bone disease of myeloma.
Fowler JA; Edwards CM; Croucher PI
Bone; 2011 Jan; 48(1):121-8. PubMed ID: 20615487
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast function in myeloma.
Roodman GD
Bone; 2011 Jan; 48(1):135-40. PubMed ID: 20601285
[TBL] [Abstract][Full Text] [Related]
11. The Proteasome and Myeloma-Associated Bone Disease.
Accardi F; Toscani D; Costa F; Aversa F; Giuliani N
Calcif Tissue Int; 2018 Feb; 102(2):210-226. PubMed ID: 29080972
[TBL] [Abstract][Full Text] [Related]
12. The multiple myeloma bone eco-system and its relation to oncogenesis.
Bataille R
Morphologie; 2015 Jun; 99(325):31-7. PubMed ID: 26005000
[TBL] [Abstract][Full Text] [Related]
13. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.
Parfitt AM
Can J Oncol; 1995 Dec; 5 Suppl 1():1-10. PubMed ID: 8853518
[TBL] [Abstract][Full Text] [Related]
14. Biology and treatment of myeloma related bone disease.
Terpos E; Christoulas D; Gavriatopoulou M
Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms, current management and next generation therapy in myeloma bone disease.
Heusschen R; Muller J; Duray E; Withofs N; Bolomsky A; Baron F; Beguin Y; Menu E; Ludwig H; Caers J
Leuk Lymphoma; 2018 Jan; 59(1):14-28. PubMed ID: 28573897
[TBL] [Abstract][Full Text] [Related]
16. Myeloma impairs mature osteoblast function but causes early expansion of osteo-progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model.
Kassen D; Lath D; Lach A; Evans H; Chantry A; Rabin N; Croucher P; Yong KL
Br J Haematol; 2016 Jan; 172(1):64-79. PubMed ID: 26767468
[TBL] [Abstract][Full Text] [Related]
17. Targeting the bone microenvironment in multiple myeloma.
Roodman GD
J Bone Miner Metab; 2010 May; 28(3):244-50. PubMed ID: 20127498
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.
Liu H; Liu Z; Du J; He J; Lin P; Amini B; Starbuck MW; Novane N; Shah JJ; Davis RE; Hou J; Gagel RF; Yang J
Sci Transl Med; 2016 Aug; 8(353):353ra113. PubMed ID: 27559096
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of multiple myeloma bone disease.
Lentzsch S; Ehrlich LA; Roodman GD
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
[TBL] [Abstract][Full Text] [Related]
20. Identification of new targets for therapy of osteolytic bone disease in multiple myeloma.
Hjertner Ø; Standal T; Børset M; Sundan A; Waage A
Curr Drug Targets; 2005 Sep; 6(6):701-11. PubMed ID: 16178802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]